Prestige And Pharmapark Add Bevacizumab To Russia Collaboration
Commercialization Agreement Signed In 2019 Over Herceptin Biosimilar
The Singapore-based biotech’s HD204 bevacizumab biosimilar is currently undergoing a Phase III clinical study • Source: Shutterstock 
